Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Oct 16;10(10):e0140379.
doi: 10.1371/journal.pone.0140379. eCollection 2015.

Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study

Affiliations
Clinical Trial

Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study

Huandong Lin et al. PLoS One. .

Abstract

Background and aims: Although many studies have indicated a relationship between nonalcoholic fatty liver disease (NAFLD) and hyperuricemia, a few studies specifically examining the effects of the severity of liver fat content (LFC) on serum uric acid (SUA) and the presence of hyperuricemia because of the limitation of the examination methods for NAFLD. In this study, we investigate the relationship between the NAFLD and SUA levels in the Chinese population using standardized quantitative ultrasound.

Methods: A community-based study was conducted from May 2010 to December 2012. A total of 4,305 people aged 45 years and above without excessive drinking were enrolled. A standard interview and anthropometric and laboratory blood parameters were collected for each person. The standardized ultrasound hepatic/renal ratio and hepatic attenuation rate was used to quantify LFC.

Results: The prevalence of NAFLD and hyperuricemia was 33.1% and 17.1%, respectively. A total of 23.5% of the NAFLD subjects had hyperuricemia, and their SUA was higher than that of non-NAFLD subjects (327.2 ± 76.8 vs 301.9 ± 77.4 μmol/L, P < 0.001). The LFC was positively correlated with SUA (r = 0.130, P < 0.001) and an independent factor for SUA (standardized β = 0.054, P < 0.001). The OR for the presence of hypreuricemia was 1.175 (95% CI 1.048-1.318; P < 0.001) with a 1 SD increase in the log LFC. LFC greater than 10% was related to elevated SUA and an increased presence of hyperuricemia.

Conclusions: LFC accumulation was associated with an increase in the prevalence of hyperuricemia and elevated SUA in our community-based population. LFC greater than 10% is related to the risk for hyperuricemia.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist

Figures

Fig 1
Fig 1. Prevalence of hyperuricemia with increases in the LFC.
In total, the prevalence of hyperuricemia was 13.7%, 14.3%, 24.2%, 24.9% and 23.6%, respectively with each additional 5% of stratified LFC from <5% to > = 20%. In male, the prevalence was 17.4%, 16.8%, 24.5%, 26.1% and 23.0%, respectively; in female, the prevalence was 11.7%, 13.2%, 24.1%, 24.4% and 24.0%, respectively. ※: compared with LFC<5%, P<0.05
Fig 2
Fig 2. ORs for 1 SD increases in variables with the prevalence of hyperuricemia from multiple logistic regression analysis.
(A) The total study population, including the variables gender, age, BMI, WC, WHR, SBP, DBP, TG, HDL-C, FPG, 2hPG, ALT, AST, GGT, LFC, BU, Cr, and eGFR, which were significantly correlated with serum uric acid in bivariate correlate analysis. (B) The male subset, including the variables age, BMI, WC, WHR, SBP, DBP, TC, TG, HDL-C, FPG, HbA1C, ALT, AST, GGT, LFC, BU, Cr and eGFR, which were significantly correlated with serum uric acid in bivariate correlation analysis. (C) The female subset, including the variables age, BMI, WC, WHR, SBP, DBP, TC, TG, HDL-C, LDL-C, FPG, 2hPG, HbA1C, ALT, AST, ALP, GGT, LFC, BU, Cr and eGFR, which were significantly correlated with serum uric acid in bivariate correlation analysis.

Similar articles

Cited by

References

    1. Grayson PC, Kim SY, LaValley M, Choi HK (2011) Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63: 102–110. - PMC - PubMed
    1. Wang J, Qin T, Chen J, Li Y, Wang L, et al. (2014) Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One 9: e114259 10.1371/journal.pone.0114259 - DOI - PMC - PubMed
    1. Li C, Hsieh MC, Chang SJ (2013) Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 25: 210–216. 10.1097/BOR.0b013e32835d951e - DOI - PubMed
    1. Grassi D, Ferri L, Desideri G, Di Giosia P, Cheli P, et al. (2013) Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des 19: 2432–2438. - PMC - PubMed
    1. Katsiki N, Papanas N, Fonseca VA, Maltezos E, Mikhailidis DP (2013) Uric acid and diabetes: Is there a link? Curr Pharm Des 19: 4930–4937. - PubMed

Publication types

MeSH terms